[go: up one dir, main page]

ES2161446T3 - Taxoides, su preparacion y las composiciones farmaceuticas que les contienen. - Google Patents

Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.

Info

Publication number
ES2161446T3
ES2161446T3 ES97908304T ES97908304T ES2161446T3 ES 2161446 T3 ES2161446 T3 ES 2161446T3 ES 97908304 T ES97908304 T ES 97908304T ES 97908304 T ES97908304 T ES 97908304T ES 2161446 T3 ES2161446 T3 ES 2161446T3
Authority
ES
Spain
Prior art keywords
radical
general formula
replaced
pharmaceutical compositions
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97908304T
Other languages
English (en)
Inventor
Herve Bouchard
Jean-Dominique Bourzat
Alain Commercon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2161446T3 publication Critical patent/ES2161446T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS TAXOIDES DE FORMULA GENERAL (I), SU PREPARACION Y LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. EN LA FORMULA GENERAL (I): Z REPRESENTA UN ATOMO DE HIDROGENO O UN RADICAL DE FORMULA GENERAL (II), DONDE R SUB,1 REPRESENTA UN RADICAL BENZOILO EN SU CASO SUSTITUIDO O UN RADICAL R 2 - O - CO, EN EL QUE R 2 REPRESENTA UN RADICAL ALCOHILO, ALCENILO, ALCINILO, CICLOALCOHILO, CICLOALCENILO, BICILOALCOHILO, FENILO EN SU CASO SUSTITUIDO O HETEROCICLO, R 3 REPRESENTA UN RADICAL ALCOHILO, ALCENILO, ALCINILO, CICLOALCOHILO, FENILO, NAFTILO O HETEROCICLICO AROMATICO, R SUB,4 REPRESENTA UN RADICAL HIDROXI O UN RADICAL ALCOXI, ALCENILOXI, ALCINILOXI EN SU CASO SUSTITUIDO, ALCANOILOXI, ALCENOILOXI, ALCINOILOXI, ALCOXIACETILO, ALCOILOXICARBONILOXI, O UN RADICAL CICLOALCOILOXI O CICLOALCENILOXI O ARILCARBONILOXI O HETEROCICLILCARBONILOXI, Y R 5 REPRESENTA UN RADICAL ALCOXI EN SU CASO SUSTITUIDO O UN RADICAL CICLOALCOILOXI O CICLOALCENILOXI. LOS NUEVOS PRODUCTOS DE FORMULAGENERAL (I), EN LA QUE Z REPRESENTA UN RADICAL DE FORMULA GENERAL (II) PRESENTAN NOTABLES PROPIEDADES ANTITUMORALES Y ANTILEUCEMICAS.
ES97908304T 1996-03-06 1997-03-05 Taxoides, su preparacion y las composiciones farmaceuticas que les contienen. Expired - Lifetime ES2161446T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602804A FR2745814B1 (fr) 1996-03-06 1996-03-06 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2161446T3 true ES2161446T3 (es) 2001-12-01

Family

ID=9489910

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97908304T Expired - Lifetime ES2161446T3 (es) 1996-03-06 1997-03-05 Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.

Country Status (34)

Country Link
US (1) US6160135A (es)
EP (1) EP0885208B1 (es)
JP (1) JP2000506158A (es)
KR (1) KR19990087398A (es)
CN (1) CN1210525A (es)
AP (1) AP1023A (es)
AT (1) ATE204266T1 (es)
AU (1) AU715228B2 (es)
BG (1) BG63693B1 (es)
BR (1) BR9707887A (es)
CA (1) CA2248195A1 (es)
CZ (1) CZ283498A3 (es)
DE (1) DE69706146T2 (es)
DK (1) DK0885208T3 (es)
EA (1) EA001516B1 (es)
EE (1) EE03611B1 (es)
ES (1) ES2161446T3 (es)
FR (1) FR2745814B1 (es)
GE (1) GEP20012517B (es)
GR (1) GR3036410T3 (es)
HU (1) HUP9902425A3 (es)
IL (1) IL125998A (es)
IS (1) IS4809A (es)
NO (1) NO983472D0 (es)
NZ (1) NZ331040A (es)
OA (1) OA10855A (es)
PL (1) PL328691A1 (es)
PT (1) PT885208E (es)
SK (1) SK121598A3 (es)
TR (1) TR199801732T2 (es)
TW (1) TW474928B (es)
WO (1) WO1997032869A1 (es)
YU (1) YU38398A (es)
ZA (1) ZA971746B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6268381B1 (en) * 1997-12-19 2001-07-31 Kabushiki Kaisha Yakult Honsha Taxane derivatives
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
AR030188A1 (es) * 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
IL145636A0 (en) * 2000-02-02 2002-06-30 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
CA2422964A1 (en) 2000-09-22 2002-03-28 Bristol Myers Squibb Company Method for reducing toxicity of combined chemotherapies
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
PA8625301A1 (es) 2004-03-05 2006-06-02 Univ Florida State Res Found Taxanos con sustituyente lactiloxilo en el c7
WO2009023967A1 (en) * 2007-08-22 2009-02-26 6570763 Canada Inc. Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
EA024186B1 (ru) 2009-10-29 2016-08-31 Авентис Фарма С.А. Применение кабазитаксела в комбинации с преднизоном или преднизолоном для лечения рака простаты
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
CA2092705C (en) * 1991-07-17 1995-11-07 Koji Saito Compound having antitumor activity, nsc-lsc1, and process for producing the same
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
ATE295363T1 (de) * 1993-03-22 2005-05-15 Univ Florida State Beta-laktame zur herstellung von taxanen mit furyl oder thienyl substituierter seitenkette
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
RO115875B1 (ro) * 1994-07-26 2000-07-28 Indena Spa Derivati de taxan, procedeu pentru prepararea acestora, intermediar pentru prepararea acestora si compozitie farmaceutica care ii contine
US6201140B1 (en) * 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives

Also Published As

Publication number Publication date
IL125998A0 (en) 1999-04-11
HUP9902425A2 (hu) 2001-04-28
AU2030297A (en) 1997-09-22
NZ331040A (en) 2000-02-28
JP2000506158A (ja) 2000-05-23
HUP9902425A3 (en) 2001-08-28
DK0885208T3 (da) 2001-10-15
ATE204266T1 (de) 2001-09-15
FR2745814B1 (fr) 1998-04-03
TW474928B (en) 2002-02-01
GEP20012517B (en) 2001-08-27
CN1210525A (zh) 1999-03-10
WO1997032869A1 (fr) 1997-09-12
IS4809A (is) 1998-07-24
BG102753A (en) 1999-09-30
ZA971746B (en) 1997-09-16
TR199801732T2 (xx) 1998-12-21
BG63693B1 (bg) 2002-09-30
AP1023A (en) 2001-11-16
OA10855A (fr) 2003-02-05
AP9801335A0 (en) 1998-09-30
CZ283498A3 (cs) 1999-01-13
YU38398A (sh) 1999-07-28
NO983472L (no) 1998-07-28
NO983472D0 (no) 1998-07-28
CA2248195A1 (fr) 1997-09-12
EP0885208A1 (fr) 1998-12-23
AU715228B2 (en) 2000-01-20
KR19990087398A (ko) 1999-12-27
EA199800795A1 (ru) 1999-02-25
EP0885208B1 (fr) 2001-08-16
IL125998A (en) 2002-02-10
DE69706146D1 (de) 2001-09-20
US6160135A (en) 2000-12-12
EE9800264A (et) 1999-02-15
PT885208E (pt) 2001-11-30
PL328691A1 (en) 1999-02-15
EE03611B1 (et) 2002-02-15
FR2745814A1 (fr) 1997-09-12
DE69706146T2 (de) 2002-05-02
GR3036410T3 (en) 2001-11-30
EA001516B1 (ru) 2001-04-23
SK121598A3 (en) 1999-01-11
BR9707887A (pt) 1999-09-21

Similar Documents

Publication Publication Date Title
ES2143187T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2161446T3 (es) Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2101513T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
FI885122A0 (fi) Oral komposition innehaollande partiklar som omfattar ett aktivt aemne.
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
DK287285D0 (da) Benzodiazepinderivat og farmaceutisk praeparat indeholdende et saadant derivat
ES2148758T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
ES2051843T3 (es) Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
ES2119325T3 (es) Compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
MX9207394A (es) Esteroides de 17-espirofuran-3'-ilideno.
ES477520A1 (es) Procedimiento para la preparacion de nuevas penicilinas.
SE8202380L (sv) Analgetisk komposition
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
DK0423697T3 (da) Lipidemulsion indeholdende en prostaglandinanalog
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
FI803264L (fi) 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel
ES2151155T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2119552T3 (es) Derivados de ciclodextrina.
ES2131864T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2121395T3 (es) Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2112670T3 (es) Derivados de ciclodextrina y su utilizacion, particularmente en cosmetica.
SE8803931D0 (sv) New alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same
ES2162126T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 885208

Country of ref document: ES